The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zebinix

50 milligram(s)/millilitre Oral suspension

BIAL-Portela & Ca, S.A.EU/1/09/514/024

Main Information

Trade NameZebinix
Active SubstancesEslicarbazepine acetate
Strength50 milligram(s)/millilitre
Dosage FormOral suspension
Licence HolderBIAL-Portela & Ca, S.A.
Licence NumberEU/1/09/514/024

Group Information

ATC CodeN03AF Carboxamide derivatives
N03AF04 eslicarbazepine

Status

Authorised/WithdrawnAuthorised
Licence Issued08/12/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back